ING Group Operating Net Profit Increases 33.0% in 2004
February 17, 2005 02:18 ET | ING Group
AMSTERDAM, The Netherlands, Feb. 17, 2005 (PRIMEZONE) -- ING Group: -- Operating net profit increases 33.0% to EUR 5,389 million -- Net profit increases 47.6% to EUR 5,968 million (EUR 2.80 per...
2020-corporate-logo-email-small.png
Nestlé coming events
February 17, 2005 02:10 ET | Nestlé S.A.
We inform you that www.ir.nestle.com has been updated with the details for the following events:   February 24, 2005   2004 full year results (press release and conference call) March 1,...
logo.png
ING Group Operating Net Profit Increases 33.0% in 2004
February 17, 2005 01:33 ET | ING Group
Divestment programme is largely completed, ING to return to full cash dividend   Operating net profit increases 33.0% to EUR 5,389 million Net profit increases 47.6% to EUR 5,968 million...
logo.png
Operationele nettowinst ING Groep stijgt over 2004 met 33,0%
February 17, 2005 01:33 ET | ING Group
Desinvesteringsprogramma grotendeels afgerond, ING keert dividend weer volledig uit in contanten   Operationele nettowinst stijgt met 33,0% tot EUR 5.389 miljoen Nettowinst neemt met 47,6%...
Straumann Outpaces the Market and Posts Record Earnings in 2004
February 17, 2005 01:09 ET | Straumann Holding AG
-- Continued strong sales growth across all regions, especially in key U.S. market, where Straumann moves up to rank #2 -- Record earnings as operating and net profits rise 31% and 24% ...
Converium Today Informs on the January 1, 2005 Treaty Renewals
February 17, 2005 01:07 ET | Converium Holding AG
ZUG, Switzerland, Feb. 17, 2005 (PRIMEZONE) -- Following its January renewals, Converium expects total gross premiums written for 2005 to exceed US$ 2 billion, which is in line with expectations. 63%...
FDA grants priority
FDA grants priority review to levetiracetam for use in childhood epilepsy
February 17, 2005 01:00 ET | UCB
Brussels, 17 February 2005: UCB Pharma Inc has been granted a priority review for the supplemental new drug application (sNDA) seeking approval of its leading anti-epilepsy drug (AED) Keppra®*...
Credit Suisse Group
Credit Suisse Group reports net income of CHF 5.6 billion for the full year 2004 and fourth quarter 2004 net income of CHF 1.0 billion
February 17, 2005 00:53 ET | Credit Suisse Group
ZURICH, Switzerland, Feb. 17, 2005 (PRIMEZONE) -- Credit Suisse Group: - All banking businesses report year-on-year profit improvements - Very good results in Private Banking and Corporate &...
PHA's Small Business
PHA's Small Business Development Program Delivers Success
February 16, 2005 22:16 ET | Port of Houston Authority
HOUSTON, Feb. 15, 2005 (PRIMEZONE) -- The Port of Houston Authority's Small Business Development Program (SBDP) achieved stellar performance results during 2004 through contract awards and purchase...
Investor Notice: Murray, Frank & Sailer LLP Has Filed a Shareholder Class Action Against Gander Mountain, Inc. -- GMTN
February 16, 2005 21:00 ET | Murray, Frank & Sailer LLP
NEW YORK, Feb. 16, 2005 (PRIMEZONE) -- Murray, Frank & Sailer LLP has filed a class action lawsuit on behalf of shareholders who purchased or otherwise acquired the securities of Gander Mountain,...